3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis

Tomoko Hayashi(University of California San Diego), Ji‐Hun Mo(Seoul National University Hospital), Xing Gong(University of California San Diego), Cyprian C. Rossetto(University of California San Diego), Angela Jang(University of California San Diego), Lucinda Beck(University of California San Diego), Gregory I. Elliott(University of California San Diego), Irina Kufareva(Scripps Research Institute), Ruben Abagyan(Scripps Research Institute), David H. Broide(University of California San Diego), Jong‐Dae Lee(University of California San Diego), Eyal Raz(University of California San Diego)
Proceedings of the National Academy of Sciences
November 15, 2007
Cited by 171

Abstract

3-Hydroxyanthranilic acid (HAA), a compound generated during tryptophan metabolism initiated by indoleamine 2,3-dioxygenase, is known to induce T cell death, but its molecular target is not known. Here we report that HAA inhibits NF-kappaB activation upon T cell antigen receptor engagement by specifically targeting PDK1. Inhibition of NF-kappaB by HAA leads to dysfunction and cell death of activated Th2 cells, which in turn suppresses experimental asthma. Inhibition of NF-kappaB and induction of apoptosis is specific to CD4 T cells because HAA does not inhibit NF-kappaB activation or induce cell death upon Toll-like receptor 4 stimulation in dendritic cells. Thus, HAA is a natural inhibitor that restrains T cell expansion and activation.


Related Papers

No related papers found

Powered by citation graph analysis